Groupe Francophone Des Myelodysplasies

This study is creating a registry to compare two standard first-line treatment approaches for a specific type of leukemia called non-high-risk acute promyelocytic leukemia (APL) in patients 70 years old or younger. It will track 400 patients to see which treatment combination lea…

This study is testing whether combining two existing cancer drugs, azacitidine and venetoclax, can effectively treat adults with higher-risk chronic myelomonocytic leukemia (CMML), a serious blood and bone marrow disorder. The main goals are to see if the combination is safe and …

This study is testing a combination of two drugs (venetoclax and azacitidine) along with an infusion of immune cells from the original stem cell donor. It is for adults whose myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) has come back after a stem cell transplant…

This early-stage study is testing the safety and initial effectiveness of a combination of two oral drugs, Onureg and Venetoclax, for people with untreated high-risk myelodysplastic syndrome (MDS) who cannot receive a stem cell transplant. The main goal is to find the safest and …